Home  >  Products  >  KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) Blocking Peptide (the N terminal of protein) (100ug)
KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) Blocking Peptide (the N terminal of protein) (100ug)

KRAS (v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KRAS antibody (Catalogue #: ARP55408_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP55408
Size: 100 ug
Weight: 22kDa
Gene: 3845
Format: Lyophilized powder
Target: KRAS is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma.This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region.
Alternative names: C-K-RAS; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; KI-RAS; KRAS1; KRAS2; NS3; RASK2
See Full Product Listings >